MentionFox
Home › funding signals › ZETAGEN THERAPEUTICS, INC.
Form D · on the record

ZETAGEN THERAPEUTICS — $12.91M Form D filing, January 2025

Before you sell to, join or invest in ZETAGEN THERAPEUTICS, INC.

MentionFox check on ZETAGEN THERAPEUTICS, INC.: only 2 sources on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/zetagen-therapeutics-inc-form-d-25000001

Check ZETAGEN THERAPEUTICS, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about ZETAGEN THERAPEUTICS, INC.?

ZETAGEN THERAPEUTICS, INC. filed an amended Form D with the Securities and Exchange Commission on 2025-01-23.

ZETAGEN THERAPEUTICS, INC. filed an amended Form D notice of an exempt securities offering with the SEC on January 23, 2025. The filing reports $12.91M sold. Its industry group is Pharmaceuticals. It names Nikhil Thakur, MD (Executive Officer, Director), Peter Finn (Executive Officer), Joe Loy (Executive Officer, Director) (SEC Form D/A, January 23, 2025).

Sell to companies like ZETAGEN THERAPEUTICS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

Peter Finn is also named on 1 other Form D filing ↓

Is this your company?

Key facts

Run the free check on ZETAGEN THERAPEUTICS, INC. →

ZETAGEN THERAPEUTICS, INC.

New Form D on file · 2025-01-23 · the record

$12.91M
raise on the record
D/A
filing
35
investors in
NEW YORK
based
Open the record →

What the record says

FilingForm D/A (amended)
Filed2025-01-23
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
BasedSYRACUSE, NEW YORK
CIK1730728
Accession0001730728-25-000003

Pitching, partnering or investing alongside them? See who really runs and owns ZETAGEN THERAPEUTICS, INC.

Free to see. No signup.

Keep reading

More on the people and the money behind ZETAGEN THERAPEUTICS, INC., from the filings we hold.

The people on this filing

What do you want to do with ZETAGEN THERAPEUTICS, INC.?

Get the full cited report on ZETAGEN THERAPEUTICS, INC.

What the filing shows about ZETAGEN THERAPEUTICS, INC.

  • 35 investors had already put money in when it filed.
  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on ZETAGEN THERAPEUTICS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look ZETAGEN THERAPEUTICS, INC. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on ZETAGEN THERAPEUTICS, INC.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives ZETAGEN THERAPEUTICS, INC.'s address as 841 East Fayette Street, Syracuse, NY 13210.

Amended on 2025-11-12: the offering size changed from $6,173,828 to $12,999,998; the amount sold changed from $83,186 to $12,908,022; the number of investors changed from 1 to 35. Figures on this page are from the amendment. Amended filing · Original filing

What the filing says

  • Offered: $12,999,998. Sold: $12,908,022. Left to sell: $91,976. (filing)
  • Investors: 35 had already invested. (filing)
  • Date of first sale: October 31, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters (marked as an estimate). It adds: “Some of the proceeds of the offering will be used for executive compensation in the normal course of business.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on ZETAGEN THERAPEUTICS, INC. See pricing

Is ZETAGEN THERAPEUTICS, INC. a real, registered company?

ZETAGEN THERAPEUTICS, INC. is a registered filer with the SEC (CIK 1730728) and has filed since 2023-02-06. 3 filings are on record, the latest on 2025-11-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs ZETAGEN THERAPEUTICS, INC.?

ZETAGEN THERAPEUTICS, INC.'s Form D of 2025-01-23 names Nikhil Thakur, MD, Peter Finn, Joe Loy and 3 more as its officers, directors or promoters.

How much has ZETAGEN THERAPEUTICS, INC. raised?

Its new offerings report $9.72M sold across 2 offerings, as its own filings state.

Filing history · 3 filings on this registrant
Form D · 2023-02-06 · $9.63MForm D · 2025-01-23 · $83K · this pageForm D/A, amended · 2025-11-12 · $12.91M 2023-02-06 2025-11-12

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Pharmaceuticals · by week

Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.

Want the whole picture on ZETAGEN THERAPEUTICS, INC.?

What the filing shows about ZETAGEN THERAPEUTICS, INC.

  • 35 investors had already put money in when it filed.
  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on ZETAGEN THERAPEUTICS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on ZETAGEN THERAPEUTICS, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for ZETAGEN THERAPEUTICS, INC.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

ZETAGEN THERAPEUTICS, INC.: Raised $12.91M, Form D filed 2025-01-23
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/zetagen-therapeutics-inc-form-d-25000001
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
ZETAGEN THERAPEUTICS raised $12.91M — SEC Form D filing, January 2025. MentionFox, 2026-11-06. https://mentionfox.com/funding/zetagen-therapeutics-inc-form-d-25000001